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ABSTRACT 
 
The antigenic properties of thirteen isolates of Newcastle disease virus were assessed 
against La Sota strain. Using one of the previously recognized formulas significant 
antigenic differences were observed and marked inhibitory activities were noticed amongst 
the isolates and their hyper-immune sera as well as that of the La Sota strain. The 
implications of these differences for Newcastle disease epidemiology and control in 
Nigeria are discussed. 
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RESUMO 
 
As propriedades antigênicas de treze isolados do vírus da doença de Newcastle foram 
comparados com amostras La Sota. Usando uma das fórmulas previamente 
reconhecidas, significantes diferenças antigênicas foram observadas e marcantes 
atividades inibitórias foram percebidas entre os isolados e seus soros hiperimunes, bem 
como das amostras La Sota. As implicações destas diferenças para a epidemiologia e 
controle da Doença de Newcastle na Nigéria são discutidos. 
Palavras-chave: vírus vacinal, vírus selvagem, doença de Newcastle, Nigéria. 
 
 
INTRODUCTION 
 
Newcastle disease virus (NDV) 
continues to pose a serious threat to the 
development of the poultry industry in 
Nigeria, other parts of Africa and Asia. The 
disease has economic and ecological 
impact on pet birds, free-living birds, as well 
as domestic birds. 
 Since the first detection and isolation 
of NDV in Nigeria in 1951 (Hill, et al., 1953), 
an average of 200 – 250 outbreaks of the 
disease are reported in the country annually 
(Okeke and Lamorde, 1988). Several of 
these outbreaks frequently occur in 
vaccinated flocks and are often attributed to 
the existence of antigenic differences 
between the vaccine virus and wild virus 
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strains (Nawathe, 1975; Ugochukwu, 1982; 
Adu, 1985). 
 Although the various strains of the 
NDV so far identified worldwide are 
antigenically related, minor antigenic 
differences still exist among strains. The 
antigenic variations found within strains are 
similar to those found among mutants 
within the same serotype (Adu, 1987). 
 These differences are expressed by 
the two surface glycoprotein antigens on 
the ND Virus – Haemagglutinin (H) and 
Neuraminidase (N) (Gomez-Lillo et al., 
1974). 
 La Sota strain of ND virus is one of 
the widely used live vaccines in Nigeria. 
This lentogenic vaccine is produced locally 
on commercial level at the National 
Veterinary Research Institute (NVRI, VOM) 
for routine immunization of commercial 
flocks. 
 In a recent survey, 13 NDV isolates 
were obtained from wild birds caught from 
Plateau, Benue and Kaduna States in 
central Nigeria. Using conventional and 
molecular techniques, there are differences 
in molecular aspects between the virus 
strains isolated (Ibu et al., 2008, in press). 
The present study was carried out to 
determine serologic antigenic relatedness 
between these isolates and the La Śota 
vaccine strain using the Cross 
Haemaglutination Inhibition test. The 
possibility of the isolates sharing a common 
origin with the vaccine strain and its 
implication in relation to vaccine failures is 
discussed. 
 
MATERIAL AND METHODS 
 
Production of Hyper-immune Serum 
 The ND virus hyper-immune serum 
(HIS) for all the 13 isolates and the La Sota 
vaccine strain was raised in six weeks old 
susceptible chickens. Seventy-five (75) 
specific antibody negative chicks were 
obtained from the Poultry Division of the 
National Veterinary Research Institute, 
(NVRI, VOM), Nigeria and raised under a 
conditioned environment at the 
experimental unit of the Viral Research 
Division of the Institute. 
 The birds were pre-screened for 
NDV antibodies and divided into 15 
experimental groups with 5 birds per group. 
Following the final screening, groups 1 – 13 
were inoculated with corresponding freshly 
harvested infective allantoic fluid of the 
virus isolate. Each bird received per-os 
(orally) 0.2 mL of 100 EID50 per mL of virus 
concentration containing a minimum of 6 
log virus titre. Group 14 was given 0.2mL of 
NDV vaccine La Sota strain. 
 The virus inoculation procedure was 
repeated at weekly intervals for four weeks. 
Twenty one days after the last inoculation, 
blood were collected from the birds  for 
serum and tested for the presence of ND 
virus antibodies. Chicks in group 15 were 
used as uninfected controls. 
 
Cross Haemggulation Inhibition (HI) Test 
A cross HI test (ß-procedure) (Oie, 
2004), was conducted on the fourteen HIS 
raised against each of the thirteen field 
virus strains and the NDV La Sota. 
 Briefly described, 25µl of phosphate 
buffered saline (PBS) (P.H 7.2) was 
dispensed into each well of a 96-well, V-
bottom plastic microtitre plate. Thereafter, 
25µl of the test serum was placed in the 
first column of the microtitre plate. A two-
fold serial dilution of the serum was made in 
PBS across the plate from 1:2 – 1:4096. 
Serial dilutions of known positive and 
negative sera were used as controls. 25µl 
of four-haemagglutination unitage (4HA) of 
previously determined virus antigen was 
added to the HIS and the control wells and 
thoroughly mixed. A back titration of 4HA 
units of the antigen was made across the 
plate. The plate was then incubated at room 
temperature (≈25-30oC) for 40 minutes. 
Afterward, 25µl of freshly prepared 1% v/v 
of chicken red blood cells (RBC) was added 
to each well and mixed using a micro-plate 
shaker. All wells of the RBC control (only 
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RBC and PBS) were allowed to settle to a 
distinct button. 
Results were read for 
haemagglutination by tilting the plates and 
observation of a “tear-drop” streaming of 
the RBCs. A serum was considered positive 
if there was an inhibition (non-settling of 
RBC) at a serum dilution of 4Log2 or 
greater. 
The extent of antigenic differences 
between two isolates was calculated from 
HI titre ratios using the formula of Archetic 
and Horsefall (1950) thus: 
 
 
R=√r1xr2 
 
Where R = ratio of extent of 
antigenic differences between two 
clones/strains when both 
clones/strains and their antisera 
are used in reciprocal cross 
serological reactions. 
r1 = Heterologous titre (virus strain 2) 
       Homologous titre (virus strain 1) 
r2 = Heterologous titre (virus strain 1) 
       Homologous titre (virus strain 2) 
 
RESULTS 
 
From this study, a reaction between 
viral isolates/antigens and their immune 
sera was observed as shown by the 
reciprocal of the mean HI titres in Table 1. 
The titres ranged between, 2 and 4096 
(table 1). The highest geometric mean titre 
(GMT) was 955 and the lowest, 196 (table 
1). 
A titre ratio as high as 32 was 
observed in a reaction between isolate Pl-
016 antigen and Pl-032 antiserum while a 
titre ratio as low as 0.016 occurred between 
isolate Bn 7 virus antigen and Pl-016 hyper-
immune serum (table 2). The maximum R-
value of 5.66 was observed in a cross 
reaction between isolate JZ 2 virus antigen 
and Pl-032 and Pl-038 hyper-immune sera 
(table 3). The lowest R-values of 0.13 was 
noticed between isolate Bn 2, and Jz2 and 
Pl-029 sera. 
For the field isolates, 42 out of 78 
(53.85%) heterologous reactions gave R-
values above 1, while 28 (35.89%) had R-
values below 1. Only 8 cross reactions 
(10.26%) had R-values equal to 1.  
Of the 13 cross reactions between 
the field virus isolates and the La Śota 
strain, 4 (30.77%) had R-values above 1. 
Six cross reactions (46.15%) gave R-values 
below 1 while 3 (23.08%) cross reactions 
had R-values equal to 1 (table 3). 
 
DISCUSSION 
 
It is evident in this study that there is 
minor antigenic variability among the 13 
field ND virus strains and the vaccine (La 
Śota) strain. A marked variation in the 
inhibitory capacity between the 
heterologous antigen and antisera is 
observed. For example, strains which show 
variability in terms of departure from the 
homologous HI titre (R> 1 or r < 1) 
accounted for 89.74% of the test result 
while strains which showed harmony (R=1) 
accounted for only about 10%. This high 
level of antigenic divergence could be of 
practical significance in relation to 
vaccination failures and the epidemiology of 
the disease in the localities. These findings 
are in agreement with those of other 
workers. Upton et al., (1953) and Bankosky 
et al., (1965) observed a significant 
diversity in antigenic components among 
the various strains of the ND Virus. Using 
different laboratory test, Gomez-Lillo et al., 
(1974); Schloer et al., (1975); and others 
identified antigenic differences between 
strains of ND viruses. Similarly, Alexander 
et al., (1999) using monoclonal antibodies, 
placed 102 ND virus isolates from 15 
countries in 16 distinct groups. It is also 
suggested that antigenic divergence 
between clones of the same strain could be 
due to the variability in the function of 
external proteins (Adu, 1985). Similarly, the 
high level of reactivity between ND virus 
strains is also attributable to the presence 
of some mutants which react more broadly 
with heterologous virus (Bratt and Gallater, 
1977). In the present study, all the strains 
had higher R-values with most of the 
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heterologous viruses than the homologous 
isolates. This observation is also true of 
their reaction with the La Sota vaccine 
strain. 
Generally, a range of R-values ≤ 0.5 
or ≥ 2 is an indication that there is a 
significant antigenic difference between two 
strains (Baba et al., 1998). In this report, 
48.71% of heterologous reactions fall within 
this range. This level of antigenic diversity 
cuts across a significant range of the 
isolates.   It  is  an  indication  that  these  
ND virus strains may not have had a 
common origin. In conclusion, it is not likely 
that the 13 virus isolates used in this study 
may have evolved from the existing La Sota 
vaccine strain. 
 
 
 
 
Table 1 - Reciprocals of cross–haemagglutination inhibition titres of  homologous and heterologous ND 
virus antigens and antisera. 
Antiserum Antigen 
Bn1
1 
Pl01
6 
Pl03
2 
Bn8 Pl03
8 
Jz2 Jz6 Pl02
9 
KD4 Bn2 Jz13 Bn7 Jz4 NDV 
Bn11 512 512 64 128 256 256 128 128 512 256 1024 64 128 2856 
Pl016 4096 2048 1024 512 4096 4096 2018 1024 4096 4096 4096 32 1124 1024 
Pl032 2048 4096 128 128 256 2058 1024 128 512 1024 1024 64 256 256 
Bn8 2048 1024 512 128 256 1024 512 156 4096 64 2048 128 256 512 
Pl038 512 1024 256 64 128 2048 512 128 1024 2048 512 256 128 128 
JZ2 1024 256 512 256 512 256 512 512 512 64 256 256 512 1024 
Jz6 512 512 256 512 512 256 512 512 512 64 256 256 64* 256 
Pl029 512 256 256 1024 4096 512 1024 512 1024 128 1024 256 64* 512 
KD4 128 256 128 64 256 128 256 128 512 256 256 512 128 256 
Bn2 256 512 256 256 1024 256 1024 256 256 4096 512 512 512 512 
Jz13 512 2048 2048 512 2048 1024 1024 1024 512 256 1024 512 1024 2048 
Jz4 256 1024 256 128 256 512 512 512 4096 512 512 256 128 1024 
Bn7 128 256 128 128 512 128 128 128 512 2048 512 128 128 128 
Lasota 512 256 1024 512 512 1024 128 512 256 256 256 512 256 512 
 
Range of 
HI titres1 
128-
4096 
256-
4096 
64-
2048 
64-
1024 
128-
4096 
128-
2048 
128-
2048 
512-
4096 
64-
2048 
256-
4096 
32-
512 
64-
1024 
512-
2048 
128- 
2048 
GMT 588 724 294 208 588 630 588 294 955 478 776 169 239  
1hyper-immune sera against field strains 
 
 
 
 
 
 
 
 
Table 2 - Titre ratios derived from Cross HI titres. 
Antiserum Antigen 
Bn 
11 
Pl 
016 
Pl 
032 
Bn 
8 
Pl 
038 
Jz 
2 
Jz 
6 
Pl02
9 
KD 
4 
Bn 
2 
Jz 
13 
Jz 
4 
Bn 
7 
NDV 
(L) 
Bn11 1 1 0.13 0.25 0.5 0.5 0.25 0.25 0.25 0.5 2 0.25 0.13 0.5 
Pl016 2 1 0.5 0.25 2 2 1 0.5 2 2 2 0.5 0.016 0.5 
Pl032 16 32 1 1 2 16 8 1 4 8 1 4 0.5 2 
Bn8 16 8 4 1 2 8 4 2 32 0.5 16 2 1 4 
Pl038 4 8 2 0.5 1 16 4 1 8 16 4 1 2 1 
Jz2 4 1 2 1 2 1 2 2 2 0.25 1 2 1 4 
Jz6 1 1 0.5 1 1 0.5 1 1 1 0.13 0.5 0.13 0.5 0.5 
Pl029 1 0.5 0.5 2 8 1 6 1 2 0.25 2 0.13 0.5 1 
KD4 0.25 0.5 0.25 0.13 0.5 0.25 0.5 0.25 1 0.5 0.5 0.25 1 0.5 
Bn2 0.063 0.13 0.063 0.63 0.25 0.063 0.25 0.063 0.063 1 0.13 0.13 0.13 0.13 
Jz13 0.5 2 2 0.5 2 2 1 1 0.5 0.25 1 1 0.5 2 
Jz4 2 8 2 1 2 4 4 4 32 4 4 1 2 8 
Bn7 1 2 1 1 4 1 1 1 4 16 4 1 1 1 
NDV(L) 1 0.5 2 1 1 2 0.25 1 0.5 0.5 0.5 0.5 1 1 
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Table 3 - R-values calculated from titre ratios according to the formular of Archetti and Horsfall (1950).  
Isolate / 
Antiserum 
Bn 
11 
Pl 
016 
Pl 
032 
Bn 
8 
Pl 
038 
Jz 
2 
Jz 
6 
Pl0 
29 
KD 
4 
Bn 
2 
Jz 
13 
Bn 
7 
Jz 
4 
NDV 
(L) 
Bn11 1 1.41 1.44 2 1.41 1.41 0.5 0.5 0.25 0.18 1 0.36 0.71 0.71 
Pl016 
 1 4 1.41 4 1.41 1 0.5 1 0.51 2 0.18 2 0.5 
Pl032 
  1 2 2 5.66 2 0.71 1 0.71 1.41 0.71 2.83 2 
Bn8 
   1 1 2.83 2 2 2.04 0.18 2.83 1 1.41 2 
Pl038 
    1 5.66 2 2.83 2 2 2.83 2.83 1.41 1 
Jz2 
     1 1 1.41 0.71 0.13 1.41 1 2.83 2.83 
Jz6 
      1 1.41 0.71 0.18 0.71 0.71 0.72 0.35 
Pl029 
       1 0.71 0.13 1.41 0.71 0.72 1 
KD4 
        1 0.18 0.5 2 3.83 0.5 
Bn2 
         1 0.5 1.44 0.72 0.25 
Jz13 
          1 1.41 2 0.32 
Bn7 
           1 1.41 1 
Jz4 
            1 2 
NDV(L) 
             1 
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